Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 122-126

  París, María M ^a   Shelton, Sharon ^a   Trujillo, Mónica ^a   Hickey, Sheila M ^a   McCracken Jr, George H ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; DEXAMETHASONE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; TROVAFLOXACIN; VANCOMYCIN;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL MUTATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS PNEUMONIAE;

EID: 0030049980     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.122     Document Type: Article

References (41)

1. Alonso, J., V. Madrigal, and M. García-Fuentes. 1991 Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin. Pediatr. Infect Dis. J. 10:256. (Letter.)
2. Asensi, F., M. C. Otero, D. Pérez-Tamarit, I. Rodríguez-Escribano, J. L. Cabedo, S. Gresa, and E. Canton. 1993. Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant Pneumococcus. J. Chemother. 5:133-134.
3. Asensi, F., D. Pérez-Tamarit, M. C. Otero, M. Gallego, S. Lianes, C. Abadia, and E. Cantó. 1989. Imipenem-cilastatin therapy in a child with meningitis caused by a multiple resistant pneumococcus. Pediatr. Infect. Dis. J. 8:895. (Letter.)
4. Bradley, J. S., and J. D. Connor. 1991. Ceftriaxone failuie in meningitis caused by Streptococcus pneumonias with reduced susceptibility to beta-lactam antibiotics. Pediatr. Infect. Dis J. 10:871-873.
5. Catalán, M. J., J. M. Fernández, A. Vazquez, E. Varela de Seijas, A. Suárez, and J. C. L. Bernaldo de Quirós. 1994. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin. Infect. Dis. 18:766-769.
6. Courvalin, P., and C. Carlier. 1986. Transposable multiple resistance in Streptococcus pneumonias. Mol. Gen. Genet. 205:291-297.
7. Dacey, R. G., and M. A. Sande. 1974. Effects of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob. Agents Chemothcr. 6:437-441.
8. Dannemann, B., J. A. McCutchan, D. Israelski, D. Antoniski, C. Leport, B. Luft, J. Nussbaum, N. Clumeck, P. Morlat, J. Chiu, J. L. Vilde, M. Orellana. D. Feigal, A. Bartok, P. Heseltine, J. Leedom, J. Remington, and the California Collaborative Treatment Group. 1992. Treatment of toxoplasmic encephalitis in patients with AIDS A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann. Intern. Med. 116:33-43.
9. Dannemann, B. H., D. M. Israelski, and J. S. Remington. 1988. Treatment of toxoplasmic encephalitis with intravenous clindamycin. Arch Intern. Med. 148:2477-2482.
10. Dhawan, V. K., and H. Thadepalli. 1981. Clindamycin: a review of fifteen years of experience. Rev. Infect. Dis. 4:1133-1153.
11. Doern, G. V. 1995. Resistance among problem respiratory pathogens in pediatrics. Pediatr. Infect. Dis. J. 14:420-423
12. Engel, H. W., N. Soedirman, J. A. Rost, W. J. van Leeuwen, and J. D. A. van Embden. 1980. Transferability of macrolide, lincomycin, and streptogramin resistances between group A. B. and D streptococci. Streptococcus pneumoniae, and Staphylococcus aureus. J. Bacteriol. 142:407-413.
13. Fasola, E. L., S. Bajaksouzian, and M. R. Jacobs. 1995. Variation in erythromycin and clindamycin susceptibility of Streptococcus pneumoniae with four test methods, abstr D13. p. 69. In Program and abstiacts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Feldman, W. E. 1976 Bacteroides fragilis yentriculitis and meningitis Report of two cases Am. J. Dis. Child 130:880-883.
15. Fernandes, P. B., W. R. Baker, L. A. Freiberg, D. J. Hardy, and E. J. McDonald. 1989. New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance. Antimicrob. Agents Chemother. 33:78-81.
16. Friedland, I. R., and K. P. Klugman. 1992. Antibiotic-resistant pneumococcal disease in South African children. Am J. Dis Child. 146:920-923.
17. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl J. Med 331:377-382
18. Friedland, I. R., S. Shelton, M. Paris, S. Rinderknecht, S. Ehrett, K. Krisher, and G. H. McCracken, Jr. 1993. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis Pediatr. Infect. Dis. J. 12:196-200.
19. Jafari, H. S., X. Sáez-Llorens, O. Ramilo, S. L. Shelton, and G. H. McCracken, Jr. 1991. Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis. Antimicrob. Agents Chemothcr. 35:220-223.
20. John, C. C. 1994. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin. Infect. Dis. 18:188-193.
21. Khuri-Bulos, N., K. McIntosh, and J. Ehret. 1973. Bacteroides brain abscess treated with clindamycin Am J. Dis Child. 126:96-98.
22. Kleiman, M. D., G. A. Weinberg, J. K. Reynolds, and S. D. Allen. 1993. Meningitis with beta-lactam-resistant Streptococcus pneumoniae, the need for early repeat lumbar puncture Pediatr. Infect. Dis J. 12:782-784.
23. Leggiadro, R. J., F. F. Barrett, P. J. Chesney, Y. Davis, and F. C. Tenover, 1994. Invasive pneumococci with high level penicillin and cephalosporm resistance at a mid-south children's hospital Pediatr Infect Dis. J. 13: 320-322
24. Leport, C., S. Bastuji-Garin, C. Perronne, D. Salmon, C. Marche, F. Bricaire, and J. L. Vildé. 1989. An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis. J. Infect. Dis. 160: 557-558
25. Mason, E. O., Jr., S. L. Kaplan, L. B. Lamberth, and J. Tillman, 1992. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniac in a Children's Hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob. Agents Chemother. 36:1703-1707
26. Murphy, T. V., G. H. McCracken, Jr., T. C. Zweighaft, and E. J. Hansen. 1981. Emergence of rifampin-resistant Haemophilus influenzae after prophylaxis. J Pediatr. 90:406-409.
27. Mustafa, M. M., O. Ramilo, J. Mertsola, R. C. Risser, B. Beutler, E. J. Hansen, and G. H. McCracken, Jr. 1989 Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus type b meningitis. J. Infect Dis. 160:818-825
28. Neu, H. C. 1991. Bacterial resistance to other agents, p. 714-722. In V Lorian (ed), Antibiotics in laboratory medicine. 3rd ed. The Williams & Wilkins Co., Baltimore
29. Paris, M. M., S. M. Hickey, M. Trujillo, S. Shelton, and G. H. McCracken, Jr. 1995. Evaluation of CP-99,219, a new fluoroquinolone. for treatment of experimental penicillin- and cephalosporin-resistant pneumoeoceal meningitis. Antimicrob. Agents Chemother 39:1243-1246.
30. Paris, M. M., S. M. Hickey, M. I. Uscher, S. Shelton, K. D. Olsen, and G. H. McCracken, Jr. 1994. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob. Agents Chemother. 38:1320-1324.
31. Paris, M. M., O. Ramilo, and G. H. McCracken, Jr. 1995. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chcmother. 39:2171-2175.
32. París, M. M., S. Shelton, K. Krisher, and G. H. McCracken, Jr. 1994. Otitis media (OM) caused by penicillin and cephalosporin resistant Streptococcus pneumoniae (P + CRSp), abstr. 1129. Program and abstracts of the American Pediatric Society and the Society for Pediatric Research Pediatr. Res 35:191A.
33. Picardi, J. L., H. P. Lewis, J. S. Tan, and J. P. Phair. 1975 Clindamycin concentrations in the central nervous system of primates before and after head trauma. J. Neurosurg. 43:717-720.
34. Pikis, A., S. Akram, J. A. Donkersloot, J. M. Campos, and W. J. Rodríguez. 1995 Penicillin-resistant pneumococci from pediatric patients in the Washington, DC, area. Arch. Pediatr. Adolese. Med. 149:30-35.
35. Rolston, K. V., and J. Hoy. 1987. Role of clindamycin in the treatment of central nervous system Am J. Med. 83:551-554.
36. Saunders, C. W., and W. R. Guild. 1980. Properties and transforming activities of two plasmids in Streptococcus pneunioniae. Mol. Gen. Genet. 180: 573-578.
37. Simon, H. J., and E. J. Yin. 1970. Microbioassay of antimicrobial agents Appl. Microbiol. 19:573-579.
38. Sloas, M. M., F. F. Barrett, P. J. Chesney, B. K. English, B. C. Hill, F. C. Tenover, and R. J. Leggiadro. 1992. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis. J. 11:662-666
39. Syrogiannopoulos, G. A., E. J. Hansen, A. L. Erwin, R. S. Munford, J. Rutledge, J. S. Reisch, and G. H. McCracken, Jr. 1988 Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation J Infect. Dis. 157:237-244.
40. Welby, P. L., D. S. Keller, J. L. Cromien, P. Tehas, and G. A. Storch. 1994. Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at Children's Hospital. Pediatr. Infect Dis. J 13:281-287.
41. Westblom, T. U., and R. B. Belshe. 1988. Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient. Scand. J. Infect. Dis 20:561-563.